| HGNC Family | Non-coding RNAs |
| Name | microRNA 770 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nmiR‐770 has emerged as a multifaceted regulator in cancer, where its expression and function appear highly context‐dependent. In triple negative breast cancer, increased miR‐770 expression is associated with enhanced chemosensitivity to doxorubicin, reduced metastatic behavior, and induction of apoptosis through targeting of effectors such as STMN1."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In ovarian cancer, lowered miR‐770‐5p levels correlate with cisplatin resistance, while its overexpression restores drug sensitivity via negative regulation of ERCC2."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " Likewise, in gastric cardia adenocarcinoma and HER2+ breast cancer, miR‐770‐5p demonstrates tumor‐suppressive properties by inhibiting cell proliferation, migration, and invasion, with added potential to enhance radiotherapy efficacy through regulation of targets such as PBK."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "3", "end_ref": "5"}]}, {"type": "t", "text": " In contrast, in certain contexts such as non‐small cell lung cancer and oral squamous cell carcinoma—as well as hepatocellular carcinoma via a Wnt/β‐catenin–mediated mechanism targeting FBXW7—miR‐770 has been associated with oncogenic features."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "8"}]}, {"type": "t", "text": " In glioma, its downregulation—partly through sponging by lncRNAs such as PCGEM1 and TPT1‐AS1—leads to derepression of targets like STMN1, thereby promoting proliferation and dysregulated autophagy."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond oncogenesis, miR‐770‐5p has shown promise as a circulating biomarker in metabolic disorders. In patients with type 1 and type 2 diabetes mellitus, serum levels of miR‐770‐5p correlate with glycemic control and are elevated in individuals with microvascular complications and diabetic nephropathy."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "11", "end_ref": "15"}]}, {"type": "t", "text": " Moreover, altered miR‐770 expression has been noted in other non‐malignant conditions such as osteoarthritis, highlighting its potential as a diagnostic and prognostic marker in diverse disease states."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "16"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMechanistically, miR‐770 modulates key signaling pathways by directly targeting genes involved in DNA repair (ERCC2), cell cycle regulation (FBXW7), EMT (DNMT3A), and cell survival (PBK, Sirt7). Its regulation by long non‐coding RNAs—including the sponging effects of PCGEM1 and TPT1‐AS1—further refines its impact on cellular processes such as apoptosis, autophagy, invasion, and response to radiotherapy."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "16"}, {"type": "fg_f", "ref": "18"}]}, {"type": "t", "text": " Collectively, these findings reflect the dualistic role of miR‐770, acting as a tumor suppressor in several cancers by enhancing chemosensitivity and inhibiting metastatic cascades, while in other contexts its upregulation may drive oncogenic processes. Future studies are warranted to better delineate the therapeutic implications of modulating miR‐770 expression across different disease settings.\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Yaming Li, Yiran Liang, Yuting Sang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-017-0030-7"}], "href": "https://doi.org/10.1038/s41419-017-0030-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29323124"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29323124"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Henan Zhao, Xiaotang Yu, Yanfang Ding, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.10736"}], "href": "https://doi.org/10.18632/oncotarget.10736"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27449101"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27449101"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Wei Guo, Zhiming Dong, Shengnan Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Promoter hypermethylation-mediated downregulation of miR-770 and its host gene MEG3, a long non-coding RNA, in the development of gastric cardia adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Carcinog (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mc.22650"}], "href": "https://doi.org/10.1002/mc.22650"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28345805"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28345805"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Hyung Chul Lee, Nam-Gu Her, Donghee Kang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Radiation-inducible miR-770-5p sensitizes tumors to radiation through direct targeting of PDZ-binding kinase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2017.116"}], "href": "https://doi.org/10.1038/cddis.2017.116"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28333152"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28333152"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Senem Noyan, Hakan Gurdal, Bala Gur Dedeoglu "}, {"type": "b", "children": [{"type": "t", "text": "Involvement of miR-770-5p in trastuzumab response in HER2 positive breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0215894"}], "href": "https://doi.org/10.1371/journal.pone.0215894"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31009516"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31009516"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Zhiwei Zhang, Yang Yang, Xiuqiang Zhang "}, {"type": "b", "children": [{"type": "t", "text": "MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Life Sci (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.lfs.2017.09.002"}], "href": "https://doi.org/10.1016/j.lfs.2017.09.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28882645"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28882645"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Bin Jia, Sanke Zhang, Shuang Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-770 promotes oral squamous cell carcinoma migration and invasion by regulating the Sirt7/Smad4 pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "IUBMB Life (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/iub.2426"}], "href": "https://doi.org/10.1002/iub.2426"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33326690"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33326690"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Wen-Jie Wu, Jia Shi, Gang Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Wnt/β-catenin signaling inhibits FBXW7 expression by upregulation of microRNA-770 in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-015-4452-5"}], "href": "https://doi.org/10.1007/s13277-015-4452-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26602384"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26602384"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Lei Jia, Yuwen Song, Luyan Mu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA TPT1-AS1 downregulates the microRNA-770-5p expression to inhibit glioma cell autophagy and promote proliferation through STMN1 upregulation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.29262"}], "href": "https://doi.org/10.1002/jcp.29262"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31637705"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31637705"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "F-Q Feng, G-S Liu, J-C Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of miR-770 indicates a favorable prognosis and suppresses tumorigenesis by modulating PI3K-AKT pathway in glioma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201904_17565"}], "href": "https://doi.org/10.26355/eurrev_201904_17565"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31002138"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31002138"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Cheng Wang, Shujun Wan, Ting Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased serum microRNAs are closely associated with the presence of microvascular complications in type 2 diabetes mellitus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep20032"}], "href": "https://doi.org/10.1038/srep20032"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26831044"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26831044"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Eiichiro Satake, Marcus G Pezzolesi, Zaipul I Md Dom, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating miRNA Profiles Associated With Hyperglycemia in Patients With Type 1 Diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/db17-1207"}], "href": "https://doi.org/10.2337/db17-1207"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29453204"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29453204"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Li Wang, Hua Li "}, {"type": "b", "children": [{"type": "t", "text": "MiR-770-5p facilitates podocyte apoptosis and inflammation in diabetic nephropathy by targeting TIMP3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BSR20193653"}], "href": "https://doi.org/10.1042/BSR20193653"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32309847"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32309847"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Y-L Zhang, X-Q Chen "}, {"type": "b", "children": [{"type": "t", "text": "Dysregulation of microRNA-770-5p influences pancreatic-β-cell function by targeting TP53 regulated inhibitor of apoptosis 1 in gestational diabetes mellitus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202001_20062"}], "href": "https://doi.org/10.26355/eurrev_202001_20062"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32016984"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32016984"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Rashin VatanIman, Seyed Hossein Malekpour, Afsoon Afshari, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-770-5p, miR-661 and miR-571 expression level in serum and tissue samples of foot ulcer caused by diabetes mellitus type II in Iranian population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11033-021-06798-9"}], "href": "https://doi.org/10.1007/s11033-021-06798-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34643918"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34643918"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Yeonho Kang, Jinsoo Song, Dongkyun Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PCGEM1 stimulates proliferation of osteoarthritic synoviocytes by acting as a sponge for miR-770."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Orthop Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jor.23046"}], "href": "https://doi.org/10.1002/jor.23046"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26340084"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26340084"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Sheyda Khalilian, Seyedeh Zahra Hosseini Imani, Sayedeh Azimeh Hosseini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The important role of miR-770 as a novel potential diagnostic and therapeutic target for human cancer and other diseases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Res Pract (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.prp.2023.154586"}], "href": "https://doi.org/10.1016/j.prp.2023.154586"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37267769"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37267769"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Senem Noyan, Ayşe Andac Ozketen, Hakan Gurdal, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-770-5p regulates EMT and invasion in TNBC cells by targeting DNMT3A."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Signal (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellsig.2021.109996"}], "href": "https://doi.org/10.1016/j.cellsig.2021.109996"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33798630"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33798630"}]}]}]}
|
| Synonyms | HSA-MIR-770, MIRN770 |
| NCBI Gene ID | 768222 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR770 has 669 functional associations with biological entities spanning 6 categories (molecular profile, organism, functional term, phrase or reference, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 16 datasets.
Click the + buttons to view associations for MIR770 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of MIR770 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR770 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR770 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR770 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR770 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR770 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MIR770 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MIR770 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MIR770 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of MIR770 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of MIR770 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of MIR770 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MIR770 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR770 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR770 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR770 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |